UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Multiple-dose pharmacokinetics, pharmacodynamics, and safety of atorvastatin, an inhibitor of HMG-CoA reductase, in healthy subjects

Clinical pharmacology and therapeutics, 1996-12, Vol.60 (6), p.687-695

1996

Volltextzugriff (PDF)

Single-Dose Gabapentin Pharmacokinetics and Safety in Healthy Infants and Children

Journal of clinical pharmacology, 2001-05, Vol.41 (5), p.507-514

2001

Volltextzugriff (PDF)

Quinapril and its metabolite quinaprilat in human milk

British journal of clinical pharmacology, 2001-05, Vol.51 (5), p.478-481

2001

Volltextzugriff (PDF)

Pregabalin Drug Interaction Studies: Lack of Effect on the Pharmacokinetics of Carbamazepine, Phenytoin, Lamotrigine, and Valproate in Patients with Partial Epilepsy

Epilepsia (Copenhagen), 2005-09, Vol.46 (9), p.1407-1413

2005

Volltextzugriff (PDF)

Tolerance and Pharmacokinetics of Single-Dose Atorvastatin, a Potent Inhibitor of HMG-CoA Reductase, in Healthy Subjects

Journal of clinical pharmacology, 1996-08, Vol.36 (8), p.728-731

1996

Volltextzugriff (PDF)

Effect of Food on the Bioavailability of Atorvastatin, an HMG-CoA Reductase Inhibitor

Journal of clinical pharmacology, 1995-10, Vol.35 (10), p.990-994

1995

Volltextzugriff (PDF)

Clinical Pharmacokinetics of Pregabalin in Healthy Volunteers

Journal of clinical pharmacology, 2010-08, Vol.50 (8), p.941-950

2010

Volltextzugriff (PDF)

Lack of Interaction of Gabapentin with Carbamazepine or Valproate

Epilepsia (Copenhagen), 1994-01, Vol.35 (1), p.155-161

1994

Volltextzugriff (PDF)

The Temporal Effect of Food on Tacrine Bioavailability

Journal of clinical pharmacology, 1994-10, Vol.34 (10), p.985-988

1994

Volltextzugriff (PDF)

Hemodynamic and hormonal effects of quinaprilat in patients with congestive heart failure

Clinical pharmacology and therapeutics, 1996-06, Vol.59 (6), p.686-698

1996

Volltextzugriff (PDF)

Pharmacokinetics of Quinapril and Its Active Metabolite, Quinaprilat, in Patients on Chronic Hemodialysis

Journal of clinical pharmacology, 1990-10, Vol.30 (10), p.938-942

1990

Volltextzugriff (PDF)

Pharmacokinetics of Pregabalin in Subjects with Various Degrees of Renal Function

Journal of clinical pharmacology, 2003-03, Vol.43 (3), p.277-283

2003

Volltextzugriff (PDF)

Minimal androgenic activity of a new oral contraceptive containing norethindrone acetate and graduated doses of ethinyl estradiol

Contraception (Stoneham), 2001-02, Vol.63 (2), p.71-76

2001

Volltextzugriff (PDF)

Pharmacokinetics of Quinapril and its Active Metabolite Quinaprilat During Continuous Ambulatory Peritoneal Dialysis

Journal of clinical pharmacology, 1990-12, Vol.30 (12), p.1136-1141

1990

Volltextzugriff (PDF)

New Drugs: First Time in Man

Journal of clinical pharmacology, 1989-11, Vol.29 (11), p.961-966

1989

Volltextzugriff (PDF)

ACE Inhibitors in the Elderly

Angiology, 1991-05, Vol.42 (5), p.387-396

1991

Volltextzugriff (PDF)

The pharmacokinetics of quinapril and quinaprilat in patients with congestive heart failure

British journal of clinical pharmacology, 1994-03, Vol.37 (3), p.302-304

1994

Volltextzugriff (PDF)

The Pharmacokinetics of Quinapril and Its Active Metabolite, Quinaprilat, in Patients with Various Degrees of Renal Function

Journal of clinical pharmacology, 1992-04, Vol.32 (4), p.344-350

1992

Volltextzugriff (PDF)

Evaluation of Quinapril on Regional Blood Flow and Cardiac Function in Patients with Congestive Heart Failure

Journal of clinical pharmacology, 1992-01, Vol.32 (1), p.70-76

1992

Volltextzugriff (PDF)

Initial human safety and tolerance study of a GABA uptake inhibitor, Cl-966: Potential role of GABA as a mediator in the pathogenesis of schizophrenia and mania

Drug development research, 1990, Vol.21 (3), p.235-242

1990

Volltextzugriff (PDF)

Single‐dose, placebo‐controlled, randomized study of AMG 785, a sclerostin monoclonal antibody

Journal of bone and mineral research, 2011-01, Vol.26 (1), p.19-26

2011

Volltextzugriff (PDF)

Comparative Effects of Verapamil and Volume Overload on Atrial Natriuretic Factors and the Renin-Angiotensin Aldosterone-Vasopressin System

Journal of clinical pharmacology, 1992-12, Vol.32 (12), p.1120-1127

1992

Volltextzugriff (PDF)

The Safety and Tolerability of Quinapril

Journal of cardiovascular pharmacology, 1990, Vol.15 Suppl 2, p.S47-S55

1990

Volltextzugriff (PDF)

Hemodynamic effects of quinapril, a novel angiotensin-converting enzyme inhibitor

Clinical pharmacology and therapeutics, 1990-07, Vol.48 (1), p.41-49

1990

Volltextzugriff (PDF)

Initial safety, tolerability pharmacodynamics, and pharmacokinetics of CI-1007 in patients with schizophrenia

Psychopharmacology bulletin, 1998, Vol.34 (1), p.93

1998

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(8)

Publikationsform

Artikel
(25)

Sprache

Englisch
(25)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Multiple-dose pharmacokinetics, pharmacodynamics, and safety of atorvastatin, an inhibitor of HMG-CoA reductase, in healthy subjects

Single-Dose Gabapentin Pharmacokinetics and Safety in Healthy Infants and Children

Quinapril and its metabolite quinaprilat in human milk

Pregabalin Drug Interaction Studies: Lack of Effect on the Pharmacokinetics of Carbamazepine, Phenytoin, Lamotrigine, and Valproate in Patients with Partial Epilepsy

Tolerance and Pharmacokinetics of Single-Dose Atorvastatin, a Potent Inhibitor of HMG-CoA Reductase, in Healthy Subjects

Effect of Food on the Bioavailability of Atorvastatin, an HMG-CoA Reductase Inhibitor

Clinical Pharmacokinetics of Pregabalin in Healthy Volunteers

Lack of Interaction of Gabapentin with Carbamazepine or Valproate

The Temporal Effect of Food on Tacrine Bioavailability

Hemodynamic and hormonal effects of quinaprilat in patients with congestive heart failure

Pharmacokinetics of Quinapril and Its Active Metabolite, Quinaprilat, in Patients on Chronic Hemodialysis

Pharmacokinetics of Pregabalin in Subjects with Various Degrees of Renal Function

Minimal androgenic activity of a new oral contraceptive containing norethindrone acetate and graduated doses of ethinyl estradiol

Pharmacokinetics of Quinapril and its Active Metabolite Quinaprilat During Continuous Ambulatory Peritoneal Dialysis

New Drugs: First Time in Man

ACE Inhibitors in the Elderly

The pharmacokinetics of quinapril and quinaprilat in patients with congestive heart failure

The Pharmacokinetics of Quinapril and Its Active Metabolite, Quinaprilat, in Patients with Various Degrees of Renal Function

Evaluation of Quinapril on Regional Blood Flow and Cardiac Function in Patients with Congestive Heart Failure

Initial human safety and tolerance study of a GABA uptake inhibitor, Cl-966: Potential role of GABA as a mediator in the pathogenesis of schizophrenia and mania

Single‐dose, placebo‐controlled, randomized study of AMG 785, a sclerostin monoclonal antibody

Comparative Effects of Verapamil and Volume Overload on Atrial Natriuretic Factors and the Renin-Angiotensin Aldosterone-Vasopressin System

The Safety and Tolerability of Quinapril

Hemodynamic effects of quinapril, a novel angiotensin-converting enzyme inhibitor

Initial safety, tolerability pharmacodynamics, and pharmacokinetics of CI-1007 in patients with schizophrenia

Suchergebnisse filtern